METHODS	Patients ( n = 1043 ) received cisplatin 80 mg/m ( 2 ) and gemcitabine 1250 mg/m ( 2 ) for up to six cycles plus bevacizumab 7.5 mg/kg ( n = 345 ) , bevacizumab 15 mg/kg ( n = 351 ) or placebo ( n = 347 ) every 3 weeks until progression .\